RESUMEN
INTRODUCCIÓN
MATERIALES Y MÉTODOS
RESULTADOS
DISCUSIÓN
BIBLIOGRAFIA
1. Alvarez MM, Vieira AC, Moura A, da Veiga GV. Insulin Resistance in Brazilian adolescent girls:
Association with overweight and metabolic disorders. Diabetes Res Clin Practice 2006 (in press).
2. Bonora E, Targher G, Alberiche M, Bonadonna R, Saggiani F, Zenere M, Monauni T, Muggeo M.
Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin
sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes
Care. 2000; 23: 57-63.
3. da Silva RC, Miranda WL, Chacra AR, Dib SA. Metabolic syndrome and insulin resistance in normal
glucose tolerant Brazilian adolescents with family history of type 2 diabetes. Diabetes Care. 2005; 28: 716-
718.
4. Emoto M, Nishizawa Y, Maekawa K, Hiura Y, Kanda H, Kawagishi T et al. Homeostasis model
assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas.
Diabetes Care. 1999; 22:818-822.
5. Gutiérrez-Fisac JL, Banegas Banegas JR, Artalejo FR, Regidor E. Increasing prevalence of overweight
and obesity among Spanish adults, 1987-1997. Int J Obes Relat Metab Disord. 2000; 24:1677-1682.
6. Khan BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000; 106:473-481.
7. Molero-Conejo E, Morales LM, Fernández V, Raleigh X, Semprun-Ferreira M, Campos G, Ryder E. Lean
adolescents with increased risk for metabolic syndrome. Arch Latinoam Nutr 2003. 53:39-46.
8. Moller DE, Kaufman KD. Metabolic syndrome: A clinical and metabolic perspective. Annu Rev Med 2004;
56:45-62.
9. Peterson KF, Shulman GI. Etiology of Insulin Resistance Am J Med 2006; 119: 105-165.
10. Phillips C, López J, Pérez F, McManus R, Roche H. Genetic and nutrient determinants of the metabolic
syndrome. Curr Opin Cardiol 2006; 21: 185-193.
11. Roche H. Fatty acids and the metabolism syndrome. Proc Nut Soc 2005; 64:23-29.
12. Saltiel AR. The molecular and physiological basis of insulin resistance: emerging implications for
metabolic and cardiovascular diseases. J Clin Invest 2000; 106: 163-165.
13. Whitelaw DC, O’Kane M, Wales JK, Barth JH. Risk factors for coronary heart disease in obese non-
diabetic subjects. Int J Obes Relat Metab Disord. 2001; 25:1042-1046.
14. Zimmet P, Boyko EJ, Collier GR, Courten M. Etiology of the Metabolic Syndrome: potential role of insulin
resistance, leptin resistance, and other players. Ann NY Acad Sci. 1999; 892:25-44.